BridgeMD
New treatment option for Pneumonia Childhood
Official title Lung Ultrasound for Guiding Antibiotic Use in Pediatric Pneumonia
ClinicalTrials.gov ID: NCT06921993
What this study is testing
- What it's testing
- Pneumonia is a major cause of illness and death in children, with an annual incidence of about 3.3 per 1,000 in those under five years old, many requiring hospitalization. The diagnosis is challenging due to the absence of a universally accepted gold standard, leading to variability in emergency settings.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 3 to 10
You may be able to join if
- Well-appearing, clinically stable patients aged 3 to 10 years, presenting to the pediatric ED with suspected pneumonia based on a combination of...
- Respiratory Symptoms: Cough, Tachypnea, Dyspnea (Increased work of breathing), Abnormal findings on auscultation.
- Systemic Symptoms: Fever, Hypoxia, Decreased appetite.
You likely can't join if
- Neonates and children up to 3 years of age, and children older than 10 years
- Children aged 3 to 10 years with any of the following factors:
- Recent hospitalization (within the past 14 days)
- Prior CXR or any other chest imaging (e.g. CT scan)
- Ongoing antibiotic therapy
- Hemodynamic instability
See the full eligibility criteria
- Well-appearing, clinically stable patients aged 3 to 10 years, presenting to the pediatric ED with suspected pneumonia based on a combination of signs and symptoms suggestive of lower respiratory tract infection (LRTI)...
- Respiratory Symptoms: Cough, Tachypnea, Dyspnea (Increased work of breathing), Abnormal findings on auscultation.
- Systemic Symptoms: Fever, Hypoxia, Decreased appetite.
- Neonates and children up to 3 years of age, and children older than 10 years
- Children aged 3 to 10 years with any of the following factors:
- Recent hospitalization (within the past 14 days)
- Prior CXR or any other chest imaging (e.g. CT scan)
- Ongoing antibiotic therapy
- Hemodynamic instability
- Respiratory failure or severe respiratory distress and/or hypoxemia, requiring urgent assessment for conditions such as pneumothorax, hemothorax, or other emergency respiratory conditions
- History of aspiration or ab ingestis pneumonia
- Underlying medical conditions predisposing to severe or recurrent pneumonia, including immunodeficiency, chronic corticosteroid use, chronic lung disease, malignancy, sickle cell disease, congenital heart disease...
The study team makes the final eligibility decision.
Where it's taking place
- San Diego, California, United States
- New Haven, Connecticut, United States
- New York, New York, United States
- Madison, Wisconsin, United States
- Petah Tikva, Israel
- Florence, Italy, Italy
- Bergamo, Italy
- Bologna, Italy
- Brescia, Italy
- Genova, Italy
- Milan, Italy
- Naples, Italy
- Novara, Italy
- Padova, Italy
- Roma, Italy
- Torino, Italy
- Trieste, Italy
Compensation & support
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 3 years to 10 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include San Diego, California, United States; New Haven, Connecticut, United States; New York, New York, United States; Madison, Wisconsin, United States; Petah Tikva, Israel; Florence, Italy, Italy and 11 more location(s). Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.